17-63689520-C-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002401.5(MAP3K3):c.872-24C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.262 in 1,600,324 control chromosomes in the GnomAD database, including 56,831 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.27 ( 6010 hom., cov: 32)
Exomes 𝑓: 0.26 ( 50821 hom. )
Consequence
MAP3K3
NM_002401.5 intron
NM_002401.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -5.31
Genes affected
MAP3K3 (HGNC:6855): (mitogen-activated protein kinase kinase kinase 3) This gene product is a 626-amino acid polypeptide that is 96.5% identical to mouse Mekk3. Its catalytic domain is closely related to those of several other kinases, including mouse Mekk2, tobacco NPK, and yeast Ste11. Northern blot analysis revealed a 4.6-kb transcript that appears to be ubiquitously expressed. This protein directly regulates the stress-activated protein kinase (SAPK) and extracellular signal-regulated protein kinase (ERK) pathways by activating SEK and MEK1/2 respectively; it does not regulate the p38 pathway. In cotransfection assays, it enhanced transcription from a nuclear factor kappa-B (NFKB)-dependent reporter gene, consistent with a role in the SAPK pathway. Alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008]
STRADA (HGNC:30172): (STE20 related adaptor alpha) The protein encoded by this gene contains a STE20-like kinase domain, but lacks several residues that are critical for catalytic activity, so it is termed a 'pseudokinase'. The protein forms a heterotrimeric complex with serine/threonine kinase 11 (STK11, also known as LKB1) and the scaffolding protein calcium binding protein 39 (CAB39, also known as MO25). The protein activates STK11 leading to the phosphorylation of both proteins and excluding STK11 from the nucleus. The protein is necessary for STK11-induced G1 cell cycle arrest. A mutation in this gene has been shown to result in polyhydramnios, megalencephaly, and symptomatic epilepsy (PMSE) syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. Additional transcript variants have been described but their full-length nature is not known. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 17-63689520-C-A is Benign according to our data. Variant chr17-63689520-C-A is described in ClinVar as [Benign]. Clinvar id is 1248554.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.341 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.273 AC: 41499AN: 151972Hom.: 5997 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
41499
AN:
151972
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.235 AC: 55516AN: 235772 AF XY: 0.234 show subpopulations
GnomAD2 exomes
AF:
AC:
55516
AN:
235772
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.260 AC: 376992AN: 1448232Hom.: 50821 Cov.: 30 AF XY: 0.258 AC XY: 185748AN XY: 719230 show subpopulations
GnomAD4 exome
AF:
AC:
376992
AN:
1448232
Hom.:
Cov.:
30
AF XY:
AC XY:
185748
AN XY:
719230
Gnomad4 AFR exome
AF:
AC:
11485
AN:
33218
Gnomad4 AMR exome
AF:
AC:
8887
AN:
43750
Gnomad4 ASJ exome
AF:
AC:
6918
AN:
25586
Gnomad4 EAS exome
AF:
AC:
1992
AN:
39304
Gnomad4 SAS exome
AF:
AC:
14956
AN:
84352
Gnomad4 FIN exome
AF:
AC:
11738
AN:
52366
Gnomad4 NFE exome
AF:
AC:
304708
AN:
1104064
Gnomad4 Remaining exome
AF:
AC:
14667
AN:
59872
Heterozygous variant carriers
0
14632
29264
43896
58528
73160
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
10028
20056
30084
40112
50140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.273 AC: 41539AN: 152092Hom.: 6010 Cov.: 32 AF XY: 0.267 AC XY: 19817AN XY: 74342 show subpopulations
GnomAD4 genome
AF:
AC:
41539
AN:
152092
Hom.:
Cov.:
32
AF XY:
AC XY:
19817
AN XY:
74342
Gnomad4 AFR
AF:
AC:
0.345282
AN:
0.345282
Gnomad4 AMR
AF:
AC:
0.206194
AN:
0.206194
Gnomad4 ASJ
AF:
AC:
0.271313
AN:
0.271313
Gnomad4 EAS
AF:
AC:
0.0554268
AN:
0.0554268
Gnomad4 SAS
AF:
AC:
0.163215
AN:
0.163215
Gnomad4 FIN
AF:
AC:
0.204365
AN:
0.204365
Gnomad4 NFE
AF:
AC:
0.279218
AN:
0.279218
Gnomad4 OTH
AF:
AC:
0.267078
AN:
0.267078
Heterozygous variant carriers
0
1491
2982
4473
5964
7455
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
412
824
1236
1648
2060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
478
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at